Savara
SVRA
#5983
Rank
S$1.49 B
Marketcap
S$7.30
Share price
-3.25%
Change (1 day)
149.16%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -S$0.17 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.16 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.17 Billion8.21%
2025 -S$0.16 Billion23.94%
2024 -S$0.13 Billion75.29%
2023 -S$70.63 Million43.38%
2022 -S$49.26 Million-11.31%
2021 -S$55.55 Million-13.3%
2020 -S$64.07 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$88.73 Million105.54%
2017 -S$43.17 Million34.11%
2016 -S$32.19 Million-37.43%
2015 -S$51.45 Million38.81%
2014 -S$37.07 Million33.62%
2013 -S$27.74 Million38.49%
2012 -S$20.03 Million24.59%
2011 -S$16.08 Million-36.5%
2010 -S$25.32 Million-3.14%
2009 -S$26.14 Million-23.28%
2008 -S$34.07 Million8.52%
2007 -S$31.4 Million-34.14%
2006 -S$47.67 Million184.43%
2005 -S$16.76 Million90.75%
2004 -S$8.79 Million190.35%
2003 -S$3.03 Million11.64%
2002 -S$2.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.3 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.45 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA